Q2 2024

Filed Aug 1, 2024 · 10-Q · 32 days after period end · 0000950170-24-088951

Q2 2024 · 10-Q

Revenue

$49.90M

+152.2% vs Q2 2023

Net Income

$32.75M

N/M vs Q2 2023

EPS Diluted

$4.67

N/M vs Q2 2023

Operating Income$24,146,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	$49.90M	$19.79M	$3.82M	$68.81M
Net Income	$32.75M	-$11.89M	-$31.04M	$21.66M
EPS Diluted	$4.67	-$3.13	-$0.46	$0.36

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR